Dalargin and electropuncture for acute hearing injury after mine blasts — RU2323019C1
Authors not yet confirmed · 2008 · Russian patent RU2323019C1
What does this source report?
The patent describes 123 patients with blast-related mixed hearing injury. Its tables report complete restoration in 22.3%, improvement in 34.7% and no effect in 43% following combined treatment. Tinnitus improvement is also reported.
- Population and setting
- 123 patients; Dalargin plus electropuncture, with middle-ear surgery described subsequently
- Evidence type
- Patent / reported experiments
- Preparation
- See the original report; formulation details require verification.
- Source language
- English abstract or source translation
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Patent case material does not establish randomized allocation, blinding or Dalargin monotherapy efficacy.
- One narrative passage reverses the restoration/improvement percentages; the summary follows the results tables.
- Mixed middle- and inner-ear injuries and associated procedures limit attribution.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Selected text reviewed
Source access and review scope
Selected source text and metadata checked; full risk-of-bias review pending.
Recorded source-check date: 2026-10-04. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Author unconfirmed. Dalargin and electropuncture for acute hearing injury after mine blasts — RU2323019C1 Russian patent RU2323019C1 2008.
Molekul research summary: https://molekul.io/research/dalargin-blast-hearing-2008. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry